Evidence map›Paper›PMID 41100195›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2025

RNA helicase DDX3X promotes NK cell survival by supporting MCL1 expression.

Eshana Mukhopadhyay, Nora Lakes, Durga Krishnamurthy, Jasmine A Tuazon, David E Ohayon, Ayad Ali, Harsha Seelamneni, Lynn H Lee, David A Hildeman, Stephen N Waggoner

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Eshana MukhopadhyayDevelopment, Stem Cells, and Regenerative Medicine Graduate Program, University of Cincinnati College of Medicine, Cincinnati, OH, United States.
Nora LakesCenter for Autoimmune Genomics and Etiology, Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Durga KrishnamurthyCenter for Autoimmune Genomics and Etiology, Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Jasmine A TuazonCenter for Autoimmune Genomics and Etiology, Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.ORCID 0000-0001-9896-9714
David E OhayonCenter for Autoimmune Genomics and Etiology, Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Ayad AliCenter for Autoimmune Genomics and Etiology, Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Harsha SeelamneniCenter for Autoimmune Genomics and Etiology, Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Lynn H LeeDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States.
David A HildemanImmunology Graduate Program, University of Cincinnati College of Medicine, Cincinnati, OH, United States.
Stephen N WaggonerDevelopment, Stem Cells, and Regenerative Medicine Graduate Program, University of Cincinnati College of Medicine, Cincinnati, OH, United States.ORCID 0000-0001-9658-2874

Funding

Stem Cell/Organoid and Genome Editing CoreP30DK078392 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI Alexander Miethke · 2007 to 2026
$24.4M
Tissue Repository CoreP30AR070549 · NIAMS · CINCINNATI CHILDRENS HOSP MED CTR · PI Leah Claire Kottyan · 2016 to 2026
$7.7M
Targeting natural killer cells to enhance HIV vaccine responsesR01AI148080 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI WAGGONER, STEPHEN N. · 2019 to 2023
$3.3M
Blocking granzyme-mediated immune suppression to enhance HIV vaccine efficacyR01AI176519 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI Vijayakumar Velu, Stephen N. Waggoner · 2023 to 2026
$2.8M
Transcription Factor Genetics in LupusR01AR073228 · NIAMS · CINCINNATI CHILDRENS HOSP MED CTR · PI KOTTYAN, LEAH CLAIRE, WAGGONER, STEPHEN N. · 2019 to 2023
$2.2M
American Heart Association PredoctoralAmerican Heart Association Predoctoral FellowshipCincinnati Children's Research Foundation Center for Pediatric GenomicsDepartment of Defense Impact HT94252410964National Institutes of Health (NIH) R01AI148080National Institutes of Health (NIH) R01AI176519National Institutes of Health (NIH) R01AR073228NIAID NIH HHS R01 AI148080NIAID NIH HHS R01 AI176519NIAMS NIH HHS P30 AR070549NIAMS NIH HHS R01 AR073228NIDDK NIH HHS P30 DK078392NIH HHS P30AR070549NIH HHS P30DK078392NIH HHS R01AI148080NIH HHS R01AI176519NIH HHS R01AR073228Research and Education FoundationThe Cincinnati Children's Hospital Flow Cytometry Core
6 · The paper itself

Abstract

DDX3 and other DEAD-box RNA helicases regulate nuclear export, translation, splicing, and metabolism of RNA. Perturbation of Ddx3x on the mouse X-chromosome in all hematopoietic cells resulted in a loss of natural killer (NK) cells, yet whether DDX3X is important only in progenitors or within NK cells remained unexplored. Herein, we deleted Ddx3x from committed NK cells by crossing Ddx3x-floxed mice to Ncr1-iCre mice. The resulting Cre+ offspring exhibited a profound deficiency of NK cells in the spleen and bone marrow. Ncr1-iCre-mediated deletion of Ddx3x also blocked in vitro generation of NK cells. CRISPR-mediated deletion of Ddx3x or pharmacological inhibition of DDX3 helicase activity in mature mouse NK cells resulted in rapid loss of cell viability, consistent with a role for DDX3X in NK cell survival. Indeed, perturbation of DDX3X in NK cells caused a substantial decrease in protein expression levels of the prosurvival mediator MCL1 but did not affect expression of the related prosurvival proteins BCL-2 or BCL-xL. Genetic deletion of the pro-apoptotic targets of MCL1, Bak and Bax, rescued the survival of NK cells following inhibition of DDX3. Mechanistically, expression levels of Mcl1 mRNA and proteasomal degradation of MCL1 protein were independent of DDX3. Instead, DDX3 bolstered MCL1 expression by supporting de novo translation of MCL1 protein. Collectively, these findings highlight a crucial role for the RNA helicase DDX3X in maintaining the NK cell compartment by supporting efficient translation of MCL1.

Indexed as

DEAD-box RNA HelicasesKiller Cells, NaturalMyeloid Cell Leukemia Sequence 1 ProteinAnimalsbcl-2-Associated X Proteinbcl-2 Homologous Antagonist-Killer ProteinCell SurvivalMiceMice, Inbred C57BLMice, Knockoutbcl-2-Associated X Proteinbcl-2 Homologous Antagonist-Killer ProteinDdx3x protein, mouseDEAD-box RNA HelicasesMcl1 protein, mouseMyeloid Cell Leukemia Sequence 1 Proteinapoptosishomeostasisinnate lymphoid cellRNA-binding protein

Identifiers

PMID41100195
PMCPMC12726062

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.